Google DeepMind is ready to start human trials of AI-designed drugs; company exec says, ‘We’re getting very close’

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in pharmaceutical innovation. President Colin Murdoch revealed the company's progress in designing cancer drugs using AI, aiming to improve trial success rates. Isomorphic Labs, born from DeepMind's AlphaFold, collaborates with Novartis and Eli Lilly, striving to create a cutting-edge drug design engine.

Most Recent